Gilead Sciences and Tango Therapeutics Announce Strategic Collaboration to Develop Next-Generation Targeted Immuno-Oncology Therapies
Gilead Sciences, Inc. (Nasdaq: GILD) and Tango Therapeutics, Inc., a company focused on the discovery and development of novel cancer therapies, today announced a global strategic collaboration to discover, develop and commercialize a pipeline of innovative targeted immuno-oncology treatments for patients with cancer.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181031005225/en/
Under the multi-year collaboration, Tango will perform target discovery and validation and Gilead will have options to worldwide rights on up to five targets emerging from Tango’s proprietary functional genomics-based discovery platform. For two programs directed to these targets, Tango will retain the option to co-develop and co-detail in the U.S. The collaboration does not include Tango’s lead programs, for which Tango will retain all rights.
“Tango has built a unique discovery platform that we hope will help create the next generation of cancer therapies,” said John McHutchison, AO, MD, Gilead’s Chief Scientific Officer and Head of R&D. “Our collaboration will combine Tango’s innovative discovery technology alongside Gilead’s drug discovery and development capabilities to build a pipeline of novel immuno-oncology therapies.”
“Gilead is the ideal partner to help us bring potentially transformative treatments to patients with cancer,” said Barbara Weber, MD, Tango’s President and Chief Executive Officer. “This partnership has significant strategic value for us. With Gilead as our partner, we can maximize the applications of our platform in immuno-oncology, while continuing to independently advance our lead programs into the clinic and beyond.”
Under the terms of the agreement, Tango will receive an upfront payment of $50 million. Tango will also be eligible to receive approximately $1.7 billion in total additional payments across all programs in the form of pre-clinical fees and development, regulatory and commercial milestone payments; and up to low double-digit tiered royalties on net sales. For those programs that Tango opts in to co-develop and co-detail, the parties will split profits and losses 50/50 for the U.S., development costs will be shared in a manner that is commensurate with product rights, and Tango will be eligible to receive milestone payments and royalties on ex-U.S. sales.
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.
About Tango Therapeutics
Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of targeted therapies to people with cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at driver genes in cancer for patients with limited treatment options. The company is focused on three core areas: counteracting tumor suppressor gene loss, reversing the ability of cancer cells to evade the immune system and identifying novel combinations that will be more effective than single agent therapy. Tango was launched in 2017 with a $55 million Series A investment funded by Third Rock Ventures and was a 2017 “Fierce 15” company. For more information, please visit www.tangotx.com.
Gilead Forward-Looking Statements
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that the parties may not realize the potential benefits of this collaboration. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2018, as filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements.
Gilead Sciences, Inc.
Sung Lee, 650-524-7792
Shant Salakian, 424-384-1841
Stephanie Simon, 617- 581-9333
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
BrandSafway Selects Rimini Street Application Management Services for Salesforce26.6.2019 16:00:00 EEST | Tiedote
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced that BrandSafway, a global leader in access, industrial services and forming and shoring solutions for the industrial, commercial and infrastructure markets, has selected Rimini Street Application Management Services (AMS) for Salesforce for its Salesforce Sales Cloud system. BrandSafway has been leveraging Rimini Street support for its Oracle Database, E-Business Suite and JD Edwards software products since 2014, and now, BrandSafway is expanding its support service scope with Rimini Street to maximize the value and business impact of Salesforce and the Salesforce Sales Cloud system. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190626005022/en/ BrandSafway Selects Rimini Street Application Management Servi
Modern Governance 4.0: Global Compliance Is Now Integrated with the World’s Leading Board Platform26.6.2019 16:00:00 EEST | Tiedote
With its second major product announcement this week, Diligent today introduced the integration of its trusted entity management technology into the Governance Cloud with new powerful reporting and dashboard functionality. Diligent Entities, formerly Blueprint OneWorld, greatly improves transparency and decreases the burden and risks for subsidiary and entity management in a fast-paced, digital environment. This launch positions Diligent as the first of its kind to provide a holistic technology platform that can power modern governance, offering leadership and the board the most effective tools – from a board portal to secure file sharing to entity compliance – accessible in one place. Business today is global and decentralized, adding layers of regulatory and ethical compliance complexity. Such distributed business interests – with various entities and subsidiaries – are often spread across multiple jurisdictions and subject to increasing regulatory obligations that make reporting and
Jabil Packaging Solutions Launches New Sustainable Packaging Services; Accelerates Sustainable Packaging Innovation26.6.2019 15:45:00 EEST | Tiedote
Jabil Packaging Solutions (JPS), a division of Jabil Inc. (NYSE: JBL), today introduced a new suite of Sustainable Packaging Services , that enable packaged goods brands to design and deliver innovative new sustainable packaging formats into the marketplace at speed. Today, companies producing Consumer Packaged Goods (CPG) are at a turning point. They must find smart ways to make their products and packaging sustainable or face increasing regulations, taxes and pushback from consumers. Companies are trying to respond to sustainability mandates and want to do the right thing for the environment. Yet assessing what is needed, sourcing the right materials and designing products that meet their corporate sustainability goals is extremely complex due to the interdependencies and expertise required for end-to-end sustainable development. “For CPGs, there has never been a bigger challenge than the transition to a truly sustainable business model,” said Jason Paladino, JPS Vice President of Te
Moody’s Analytics Wins Enterprise-Wide Stress Testing Product of the Year at Risk Technology Awards26.6.2019 13:00:00 EEST | Tiedote
Moody’s Analytics, a global provider of financial intelligence, has won Enterprise-Wide Stress Testing Product of the Year at the 2019 Risk Technology Awards. It’s one of six categories won across finance, accounting, regulatory, and credit functions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190626005246/en/ Traditionally, stress testing exercises have required the participation of many groups within an institution and often took several months to complete. Today, banks must be able to respond to regulatory and management requests faster, while also extracting business value from the results. Moody’s Analytics helps banks overcome the challenges of stress testing. Our solutions improve data quality and integrity and make efficient use of resource and technology investments, while delivering industry-leading Moody’s Analytics modeling expertise. “Stress testing plays a critical role in how banks manage risk. Understandi
Tech Giant Alibaba Cloud Partners With UAE’s Group 42 to Host First MEA Internet Summit26.6.2019 12:19:00 EEST | Tiedote
Alibaba Cloud, the data intelligence backbone of Alibaba Group, today held its inaugural Middle East and Africa (MEA) Internet Summit in partnership with UAE-based Artificial Intelligence (AI) and Cloud Computing leader Group 42. Drawing the participation of tech experts and executives from the region’s top 100 internet companies, the summit took place during the Ghyma Conference 2019. Among the distinguished guests were HE Saif Mohammed Al Hajri, Chairman of the Department of Economic Development Abu Dhabi, His Excellency Mohammed Gheyath, Executive Director Information Security Operations, Abu Dhabi Digital Authority, Ibrahim Ajami, Head of Mubadala Ventures, Peng Xiao, CEO of Group 42, and Selina Yuan, President of Alibaba Cloud Intelligence International. Panelists and speakers covered an extensive range of topics over 10 keynote speeches. These included maximising the potential of cloud and AI, leveraging the internet to thrive in the new digital age, taking e-commerce to the next
SIGMOLECS®: the Most Advanced Technology Available for Regenerative Medicine26.6.2019 12:00:00 EEST | Tiedote
Contrad Swiss, a pharmaceutical company focused on breakthrough, innovative products that reframe the world of medicine, announces a new partnership with Dr JO Serrentino to bring to the market effective biomedical remedies unlike any other. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190626005031/en/ Photo by Contrad Swiss SIGMOLECS® Technology was conceived and engineered by Dr Serrentino exclusively for Contrad Swiss. SIGMOLECS® uses the highest bioavailable signaling molecules to summon and target biological pathways for precise programming at the cellular level. The result is like a program code of the cells, deploying them to organize into specific patterns. SIGMOLECS® talks to the cells in their language. ACTV8SKN® – Actuator - contains the exclusive SIGMOLECS® Technology. ACTV8SKN® is an odorless fluid gel of peptide-bonded amino acids, specifically engineered for a complete signaling spectrum that awakens cell cy
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme